Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

Multitarget stool DNA tests — which are becoming more popular in the United States — have shown increased sensitivity over fecal immunochemical tests (FITs) for early colorectal cancer (CRC) screening ...

A fecal immunochemical testing-based screening program in Spain was linked to durable decline in colorectal cancer mortality ...

Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

An at-home FIT test is a screening tool that may detect colon cancer. It works by testing for blood in the stool, which can be an early sign of colon cancer caused by colorectal polyps that leak blood ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

A pragmatic cluster-randomized trial across 8 CHC sites (Boston and Los Angeles) enrolled 5127 adults aged 45–75 years overdue for screening, randomizing clinics to FIT versus FIT-DNA outreach.

Please provide your email address to receive an email when new articles are posted on . Patients who received mailed outreach had a higher rate of screening completion at 6 months vs. those who ...